Patent: 9,981,087
✉ Email this page to a colleague
Summary for Patent: 9,981,087
Title: | Automatic injection device |
Abstract: | Automatic injection device includes a housing, a syringe, a plunger, and a syringe carrier. The housing includes a barrel. The barrel includes an elongated window to allow viewing of contents inside the housing. The syringe is disposed within the housing and has a reservoir. The plunger is at least partially disposed within the syringe and includes a visual indicator. The syringe carrier is disposed within the housing and configured to contain the syringe and displace the syringe within the housing between a first position and a second position. The syringe carrier can have at least one opening and at least one pair of legs defining at least a portion of the at least one opening. |
Inventor(s): | Shang; Sherwin S. (Vernon Hills, IL), Julian; Joseph F. (Libertyville, IL), Li; Chuan (Deerfield, IL), Tsvirko; Eduard N. (Arlington Heights, IL), Chim; Edwin (Vernon Hills, IL), Somashekar; Shubha Chethan (Waukegan, IL), Ozdaryal; Esra (Deerfield, IL) |
Assignee: | AbbVie Inc. (North Chicago, IL) |
Application Number: | 14/673,463 |
Patent Claims: | see list of patent claims |
Details for Patent 9,981,087
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 12/31/2002 | ⤷ Try a Trial | 2031-09-22 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 02/21/2008 | ⤷ Try a Trial | 2031-09-22 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 04/24/2013 | ⤷ Try a Trial | 2031-09-22 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 09/23/2014 | ⤷ Try a Trial | 2031-09-22 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 11/23/2015 | ⤷ Try a Trial | 2031-09-22 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |